AC
MDGL icon

AXQ Capital’s Madrigal Pharmaceuticals MDGL Stock Holding History

AXQ Capital’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$499K Buy
+929
New +$476K 0.05% 490
2024
Q3 		– Sell
-892
Closed -$250K – 534
2024
Q2 		$250K Buy
+892
New +$212K 0.06% 385
2024
Q1 		– Sell
-2,200
Closed -$509K – 790
2023
Q4 		$509K Buy
+2,200
New +$385K 0.14% 263

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AXQ Capital's MDGL Position: Q2 2026 in Review

AXQ Capital opened a new position in Madrigal Pharmaceuticals (MDGL) in Q2 2026: 929 shares worth $499K. The stake represents 0.05% of the portfolio and ranks #490 among its holdings. This is a return to the name: AXQ Capital previously reported a position in MDGL as recently as Q2 2024.

AXQ Capital first reported a position in MDGL in Q4 2023 and has held it in 3 quarters since. The position peaked at $509K in Q4 2023. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • AXQ Capital held 929 shares of Madrigal Pharmaceuticals worth $499K as of Q2 2026.
  • Madrigal Pharmaceuticals was a new AXQ Capital position in Q2 2026.
  • Madrigal Pharmaceuticals made up 0.05% of AXQ Capital's portfolio in Q2 2026, its #490 holding.
  • AXQ Capital first reported a position in Madrigal Pharmaceuticals in Q4 2023 and has held it in 3 quarters since.
  • AXQ Capital's Madrigal Pharmaceuticals position peaked at $509K in Q4 2023.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.